Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Scoazec, Jean-Yves
2005.
Tumeurs endocrines : biologie et physiopathologie.
Annales de Pathologie,
Vol. 25,
Issue. 6,
p.
447.
Rehfeld, Jens F.
and
Goetze, Jens Peter
2005.
Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma.
Vol. 4,
Issue. ,
p.
23.
Blois, Anna
Srebro, Boleslaw
Mandalà, Maurizio
Corti, Angelo
Helle, Karen B.
and
Serck-Hanssen, Guldborg
2006.
The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.
Regulatory Peptides,
Vol. 135,
Issue. 1-2,
p.
78.
Zhang, Kuixing
Rao, Fangwen
Wen, Gen
Salem, Rany M.
Vaingankar, Sucheta
Mahata, Manjula
Mahapatra, Nitish R.
Lillie, Elizabeth O.
Cadman, Peter E.
Friese, Ryan S.
Hamilton, Bruce A.
Hook, Vivian Y.
Mahata, Sushil K.
Taupenot, Laurent
and
O’Connor, Daniel T.
2006.
Catecholamine storage vesicles and the metabolic syndrome: the role of the chromogranin A fragment pancreastatin.
Diabetes, Obesity and Metabolism,
Vol. 8,
Issue. 6,
p.
621.
BURKITT, M. D.
and
PRITCHARD, D. M.
2006.
Review article: pathogenesis and management of gastric carcinoid tumours.
Alimentary Pharmacology & Therapeutics,
Vol. 24,
Issue. 9,
p.
1305.
Chakraborty, Tandra R.
Tkalych, Oleg
Nanno, Daniela
Garcia, Angelo L.
Devi, Lakshmi A.
and
Salton, Stephen R.J.
2006.
Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress.
Brain Research,
Vol. 1089,
Issue. 1,
p.
21.
Blois, Anna
Holmsen, Holm
Martino, Guglielmo
Corti, Angelo
Metz-Boutigue, Marie-Hélène
and
Helle, Karen B.
2006.
Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine.
Regulatory Peptides,
Vol. 134,
Issue. 1,
p.
30.
Glattard, Elise
Angelone, Tommaso
Strub, Jean‐Marc
Corti, Angelo
Aunis, Dominique
Tota, Bruno
Metz‐Boutigue, Marie‐Hélène
and
Goumon, Yannick
2006.
Characterization of natural vasostatin‐containing peptides in rat heart.
The FEBS Journal,
Vol. 273,
Issue. 14,
p.
3311.
Bitsche, M.
Schrott-Fischer, A.
Hinterhoelzl, J.
Fischer-Colbrie, R.
Sergi, C.
Glueckert, R.
Humpel, C.
and
Marksteiner, J.
2006.
First localization and biochemical identification of chromogranin B- and secretoneurin-like immunoreactivity in the fetal human vagal/nucleus solitary complex.
Regulatory Peptides,
Vol. 134,
Issue. 2-3,
p.
97.
DI FELICE, VALENTINA
CAPPELLO, FRANCESCO
MONTALBANO, ANTONELLA
ARDIZZONE, NELLA
CAMPANELLA, CLAUDIA
DE LUCA, ANGELA
AMELIO, DANIELA
TOTA, BRUNO
CORTI, ANGELO
and
ZUMMO, GIOVANNI
2006.
Human Recombinant Vasostatin‐1 May Interfere with Cell–Extracellular Matrix Interactions.
Annals of the New York Academy of Sciences,
Vol. 1090,
Issue. 1,
p.
305.
Shulkes, Arthur
Baldwin, Graham S.
and
Giraud, Andrew S.
2006.
Physiology of the Gastrointestinal Tract.
p.
1223.
Gallo, Maria Pia
Levi, Renzo
Ramella, Roberta
Brero, Alessia
Boero, Ombretta
Tota, Bruno
and
Alloatti, Giuseppe
2007.
Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium.
American Journal of Physiology-Heart and Circulatory Physiology,
Vol. 292,
Issue. 6,
p.
H2906.
Mattsson, Niklas
Rüetschi, Ulla
Podust, Vladimir N.
Stridsberg, Mats
Li, Susann
Andersen, Oluf
Haghighi, Sara
Blennow, Kaj
and
Zetterberg, Henrik
2007.
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis.
Journal of Neurochemistry,
Vol. 103,
Issue. 5,
p.
1932.
Belloni, Daniela
Scabini, Silvia
Foglieni, Chiara
Veschini, Lorenzo
Giazzon, Alessio
Colombo, Barbara
Fulgenzi, Alessandro
Helle, Karen B.
Ferrero, Maria Elena
Corti, Angelo
and
Ferrero, Elisabetta
2007.
The vasostatin‐I fragment of chromogranin A inhibits VEGF‐induced endothelial cell proliferation and migration.
The FASEB Journal,
Vol. 21,
Issue. 12,
p.
3052.
Tota, Bruno
Quintieri, Anna Maria
Di Felice, Valentina
and
Cerra, Maria Carmela
2007.
New biological aspects of Chromogranin A-derived peptides: Focus on vasostatins.
Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology,
Vol. 147,
Issue. 1,
p.
11.
Cappello, Sandra
Angelone, Tommaso
Tota, Bruno
Pagliaro, Pasquale
Penna, Claudia
Rastaldo, Raffaella
Corti, Angelo
Losano, Gianni
and
Cerra, Maria Carmela
2007.
Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism.
American Journal of Physiology-Heart and Circulatory Physiology,
Vol. 293,
Issue. 1,
p.
H719.
Montero‐Hadjadje, M.
Vaingankar, S.
Elias, S.
Tostivint, H.
Mahata, S. K.
and
Anouar, Y.
2008.
Chromogranins A and B and secretogranin II: evolutionary and functional aspects.
Acta Physiologica,
Vol. 192,
Issue. 2,
p.
309.
Portela-Gomes, Guida Maria
Grimelius, Lars
and
Stridsberg, Mats
2008.
Prohormone convertases 1/3, 2, furin and protein 7B2 (Secretogranin V) in endocrine cells of the human pancreas.
Regulatory Peptides,
Vol. 146,
Issue. 1-3,
p.
117.
Rehfeld, Jens F.
Zhu, Xiaorong
Norrbom, Christina
Bundgaard, Jens R.
Johnsen, Anders H.
Nielsen, John E.
Vikesaa, Jonas
Stein, Jeffrey
Dey, Arunangsu
Steiner, Donald F.
and
Friis-Hansen, Lennart
2008.
Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17.
Biochemical Journal,
Vol. 415,
Issue. 1,
p.
35.
Dicou, Eleni
2008.
Biologically active, non membrane‐anchored precursors – an overview.
The FEBS Journal,
Vol. 275,
Issue. 9,
p.
1960.